Clinical Trials in San Francisco

Showing 7161-7180 of 9,883 trials

Study of SCY-635, Pegasys and Copegus in Hepatitis C

NCT01265511

This study will examine the effectiveness of 28 days of triple combination therapy including SCY-635 with peginterferon alfa 2a and ribavirin in reducing serum HCV RNA levels. An additional 20 weeks of treatment with the currently approved standard of care will be offered to all participants. The Week 24 visit will be the last on-study visit. After the Week 24 visit, all subjects with undetectable HCV RNA will be given the option to continue treatment with standard of care for an additional 24 weeks (out to Week 48) under the care of their Principal Investigator.

Hepatitis C Infection

Scynexis, Inc.10 participantsStarted Nov 2010

San Francisco, California, United States • Durham, North Carolina, United States • San Antonio, Texas, United States +1 more locations

COMPLETEDPhase 1< 1 mile

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

NCT01764477

Laboratory studies suggest that the study drug may stop cancer cells from growing by affecting an interaction between proteins in the cells referred to as cAMP-response element-binding protein and ß-catenin. The purpose of this research study is to determine the highest safe dose of study drug that may be used when it is given together with a chemotherapy drug to patients with cancer of the pancreas.

Advanced Pancreatic CancerMetastatic Pancreatic CancerPancreatic Adenocarcinoma

Prism Pharma Co., Ltd.20 participantsStarted Apr 2013

Los Angeles, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States +2 more locations

Study of SCY-635, Pegasys and Copegus in Hepatitis C

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

Find Trials by Condition in San Francisco

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)

Evaluation of the Ability to Detect Bowel Gas During Laparoscopic Surgery

Subcutaneous Botulinum Toxin for Cutaneous Allodynia - Enriched Responder Trial

FNA Tumor Sampling for CD137 Modulation: A Pilot Study

A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)

The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial

A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis

A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease

Multi-Center Comparative Trial of the ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System

Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty

Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment

Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease

Safety Study to Evaluate FluMist in Immunocompromised Children

Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease